TBD | The Rise of Off-Brand Ozempic
What Next | Daily News and Analysis

TBD | The Rise of Off-Brand Ozempic

2024-08-18
GLP-1 drugs like Ozempic and Wegovy are in high demand and short supply. The internet makes it easy for you to have a compounding pharmacy whip you up a batch—but should you?Guest: Kate Knibbs, senior writer at Wired. Want more What Next TBD? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherev...
View more
Comments (3)

More Episodes

All Episodes>>

Get this podcast on your phone, Free

Creat Yourt Podcast In Minutes

  • Full-featured podcast site
  • Unlimited storage and bandwidth
  • Comprehensive podcast stats
  • Distribute to Apple Podcasts, Spotify, and more
  • Make money with your podcast
Get Started
It is Free